Indeed, supplementation of formate, an intermediate in one-carbon metabolism downstream of serine, in combination with anti-PD-1 therapy, enhances CD8+ T cell accumulation in the TME and mediates better control of tumor growth (Rowe et al., 2023). Here, CD8A is linked to neoplasm.